Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Home
A Novel Pdia3/fto/usp20 Positive Feedback Regulatory Loop Induces Osteogenic Differentiation Of Preosteoblast In Osteoporosis.

Home
A Novel Pdia3/fto/usp20 Positive Feedback Regulatory Loop Induces Osteogenic Differentiation Of Preosteoblast In Osteoporosis.

Related Concept Videos

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Skeleton and Calcium Homeostasis

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Related Experiment Video

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

A novel PDIA3/FTO/USP20 positive feedback regulatory loop induces osteogenic differentiation of preosteoblast in

Fei Zhang¹, Chen Liu², Zhiyong Chen^3,4

¹First Department of Orthopaedics, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.

Cell Biology International

|February 7, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Protein disulfide isomerase family A, member 3 (PDIA3) promotes bone formation by enhancing osteogenic differentiation. This process involves FTO-mediated PDIA3 mRNA methylation and a PDIA3-USP20 feedback loop, offering new therapeutic targets for osteoporosis.

Keywords:

PDIA3 m6A methylation osteogenic differentiation osteoporosis preosteoblast protein degradation

More Related Videos

Osteoclast Derivation from Mouse Bone Marrow

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

Related Experiment Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Osteoclast Derivation from Mouse Bone Marrow

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

Area of Science:

Biochemistry
Molecular Biology
Cell Biology

Background:

Osteoporosis is a major skeletal disease in aging populations, increasing fracture risk.
Understanding osteoporosis mechanisms is crucial for developing effective treatments.
Osteogenic differentiation of preosteoblasts is a key process for bone formation.

Purpose of the Study:

To investigate the role of Protein disulfide isomerase family A, member 3 (PDIA3) in preosteoblast osteogenic differentiation.
To elucidate the regulatory mechanism of PDIA3 in bone formation.
To identify potential therapeutic targets for osteoporosis.

Main Methods:

Methylated RNA immunoprecipitation (MeRIP) for m6A RNA methylation detection.
RNA decay assays for mRNA stability analysis.
Co-immunoprecipitation (Co-IP) for protein-protein interaction and phosphorylation studies.

Main Results:

PDIA3 significantly promoted osteogenic differentiation of MC3T3-E1 preosteoblasts.
FTO alpha-ketoglutarate dependent dioxygenase (FTO) suppressed PDIA3 mRNA methylation, reducing mRNA stability.
Ubiquitin specific peptidase 20 (USP20) enhanced FTO levels by inhibiting its degradation, while PDIA3 increased FTO levels via USP20 phosphorylation, forming a positive feedback loop.

Conclusions:

PDIA3 plays a critical role in regulating osteogenic differentiation of preosteoblasts.
A regulatory mechanism involving PDIA3, FTO, and USP20 controls osteoblast differentiation and bone formation.
These findings highlight potential therapeutic targets for osteoporosis treatment and prevention.